Clinical Pharmacology · Special Populations
Pregnancy and Lactation
On this page 6 sections
In 30 seconds
Pregnancy and lactation change how drugs move through the body and whether they reach the fetus or infant, so dosing and drug choice must adapt rather than default to "avoid everything." The central clinical principle is balancing risk: untreated maternal disease can harm the pregnancy as much as, or more than, a medication does. A short list of well-documented teratogens deserves special caution, but most medications used in pregnancy and breastfeeding are manageable with informed, individualized decisions rather than blanket avoidance.
The college version
Pharmacokinetic changes in pregnancy
Pregnancy alters every phase of drug handling. Plasma volume and total body water expand substantially, diluting many drugs so measured concentrations fall even at an unchanged dose. Serum albumin drops, raising the free (unbound, active) fraction of drugs that normally bind protein. Cardiac output and renal blood flow rise, accelerating glomerular filtration, so drugs cleared mainly by the kidney may leave the body faster — some medications therefore need higher or more frequent dosing to stay effective, the opposite of what intuition suggests. Gastric emptying slows, delaying onset of oral drugs. Hepatic enzyme activity shifts in both directions — some pathways speed up, others slow down — so the net effect on any given drug must be judged individually.
Placental transfer and critical windows
The placenta acts as a selective interface rather than a solid barrier. Small, lipophilic, un-ionized, and unbound molecules cross most readily; large, charged, or heavily protein-bound molecules cross less easily. Timing of exposure matters as much as the drug itself. The first trimester, when organs are forming (organogenesis), carries the highest risk of structural malformation. Later exposure, after organs have formed, is less likely to cause structural defects but can still impair growth, organ maturation, or neurodevelopment, and can affect the newborn directly around delivery.
From letter categories to narrative labeling
The FDA's old A/B/C/D/X pregnancy categories were retired because they compressed a complex, evidence-dependent risk picture into a false hierarchy: they blurred dose, timing, and quality of evidence, encouraged treating drugs as simply "safe" or "unsafe," and ignored lactation entirely. The Pregnancy and Lactation Labeling Rule replaced letters with narrative sections summarizing available data, the risk of untreated illness, and dosing considerations — giving clinicians information to individualize care rather than a shortcut grade.
The balancing principle
The relevant question is never "is this drug safe?" in isolation, but which option — a given medication, an alternative, or no treatment — carries the lowest combined risk to the pregnant person and fetus. Untreated seizures risk hypoxia and trauma; untreated asthma risks maternal and fetal hypoxemia; poor glycemic control raises malformation and stillbirth rates; untreated hypertension threatens maternal and placental health; untreated depression carries risks of self-harm and impaired bonding; untreated infection can trigger preterm labor. Stopping medication is not automatically the safer choice.
Recognized teratogens
A short list of drugs carries well-established teratogenic risk and warrants particular caution: isotretinoin, thalidomide, valproate, warfarin, ACE inhibitors and ARBs, methotrexate, lithium, tetracyclines, and live vaccines. Alcohol deserves separate emphasis as the leading preventable cause of developmental disability, a reminder that major risks are not limited to prescription drugs.
Lactation
Milk transfer follows similar principles to placental transfer — size, lipid solubility, protein binding, and maternal plasma level all matter — plus maternal and infant metabolism. Reassuringly, most maternal medications are compatible with breastfeeding at usual doses, and breastfeeding's benefits generally outweigh small theoretical exposures. Timing a dose right after a feed, so levels are lowest before the next one, can further reduce infant exposure. Only a small number of drugs are genuinely contraindicated in lactation, and clinicians should consult a dedicated, current lactation drug reference rather than general labeling, which tends to be overly conservative.
Preconception counseling and shared decision-making
Ideally, planning starts before conception: reviewing current medications, starting folic acid to reduce neural tube defect risk, and switching known teratogens to safer alternatives ahead of time when feasible. Because many pregnancies are unplanned, pregnancy-conscious prescribing should be a default for patients of reproductive age. Throughout, decisions should be shared with the patient, weighing evidence quality, disease severity, and personal values.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Picture your body as a swimming pool. Pregnancy adds extra water to the pool, so anything dissolved in it — including medicine — spreads out and gets weaker per cup. Some of the "nets" in your blood that usually hold medicine (proteins) get thinner too, so more medicine floats around free and active. Your kidneys work like a faster drain, flushing some medicines out quicker, so sometimes you need more medicine, not less, to get the same effect. The baby gets some of what's in the pool through the placenta — small, sneaky substances cross over more easily than big clunky ones. Early pregnancy is the baby's construction phase, when body parts are being built, so it's the riskiest time for a building mistake. Later on, the parts are already built, so problems then are more about growing well than being built wrong. Doctors used to slap a simple letter grade on every medicine, like a report card, but that was too simple, so now they write a fuller explanation instead. The biggest idea: not taking medicine can also hurt the baby, if it lets Mom's illness spiral out of control. And breastfeeding is like the pool again — most medicines are fine in small amounts in breast milk, and only a few are truly off-limits.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient with well-controlled epilepsy asks whether she should stop her antiseizure medication as soon as she learns she is pregnant. What core principle should guide the counseling response?
Show answer
She generally should not stop it without guidance, because uncontrolled seizures — with risks like falls, injury, and oxygen deprivation to the fetus — can be more dangerous to the pregnancy than continuing appropriate treatment, so the decision should weigh adjusting therapy against the real danger of untreated epilepsy.
This is like deciding whether to remove a bike helmet because helmets aren't perfectly risk-free — taking it off creates a bigger danger than any small risk from wearing it, so the better move is keeping the protection and fine-tuning it with a doctor.
A breastfeeding patient is prescribed a medication compatible with lactation but wants to minimize her infant's exposure. What practical timing strategy can help, and why?
Show answer
Taking the dose right after finishing a breastfeeding session, so the drug level in milk has the most time to decline before the next feed, reducing the amount the infant receives.
It's like waiting for a splash in a pond to settle before someone drinks from it — dosing right after a feed gives the medicine "splash" the longest time to calm down before the baby drinks again.
Quick check
3 questions here. Answers stay hidden until you check.
Why were the old A/B/C/D/X pregnancy risk categories replaced with narrative labeling?
Which best describes molecules that cross the placenta easily?
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

